User menu

Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study.

Bibliographic reference Pulford, David J ; Harter, Philipp ; Floquet, Anne ; Barrett, Catherine ; Suh, Dong Hoon ; et. al. Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study.. In: BMC Medical Ethics, Vol. 17, no.1, p. 63 (2016)
Permanent URL http://hdl.handle.net/2078.1/189119
  1. Burke Wylie, Evans Barbara J, Jarvik Gail P, Return of results: Ethical and legal distinctions between research and clinical care : AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMINARS IN MEDICAL GENETICS), 10.1002/ajmg.c.31393
  2. Darnell Andrew J., Austin Howard, Bluemke David A., Cannon Richard O., Fischbeck Kenneth, Gahl William, Goldman David, Grady Christine, Greene Mark H., Holland Steven M., Hull Sara Chandros, Porter Forbes D., Resnik David, Rubinstein Wendy S., Biesecker Leslie G., A Clinical Service to Support the Return of Secondary Genomic Findings in Human Research, 10.1016/j.ajhg.2016.01.010
  3. Husedzinovic Alma, Ose Dominik, Schickhardt Christoph, Fröhling Stefan, Winkler Eva C, Stakeholders’ perspectives on biobank-based genomic research: systematic review of the literature, 10.1038/ejhg.2015.27
  4. Clayton Ellen Wright, McGuire Amy L., The legal risks of returning results of genomics research, 10.1038/gim.2012.10
  5. Prucka Sandra K., Arnold Lester J., Brandt John E., Gilardi Sandra, Harty Lea C., Hong Feng, Malia Joanne, Pulford David J., An Update to Returning Genetic Research Results to Individuals: Perspectives of the Industry Pharmacogenomics Working Group : I-PWG Update on Returning Genetic Research Results to Individuals, 10.1111/bioe.12073
  6. McGuire A. L., Knoppers B. M., Zawati M. H., Clayton E. W., Can I be sued for that? Liability risk and the disclosure of clinically significant genetic research findings, 10.1101/gr.170514.113
  7. Green Robert C., Berg Jonathan S., Grody Wayne W., Kalia Sarah S., Korf Bruce R., Martin Christa L., McGuire Amy L., Nussbaum Robert L., O’Daniel Julianne M., Ormond Kelly E., Rehm Heidi L., Watson Michael S., Williams Marc S., Biesecker Leslie G., ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing, 10.1038/gim.2013.73
  8. Knoppers Bartha Maria, Joly Yann, Simard Jacques, Durocher Francine, The emergence of an ethical duty to disclose genetic research results: international perspectives, 10.1038/sj.ejhg.5201690
  9. Knoppers Bartha Maria, Zawati Ma'n H., Sénécal Karine, Return of genetic testing results in the era of whole-genome sequencing, 10.1038/nrg3960
  10. Jarvik Gail P., Amendola Laura M., Berg Jonathan S., Brothers Kyle, Clayton Ellen W., Chung Wendy, Evans Barbara J., Evans James P., Fullerton Stephanie M., Gallego Carlos J., Garrison Nanibaa’ A., Gray Stacy W., Holm Ingrid A., Kullo Iftikhar J., Lehmann Lisa Soleymani, McCarty Cathy, Prows Cynthia A., Rehm Heidi L., Sharp Richard R., Salama Joseph, Sanderson Saskia, Van Driest Sara L., Williams Marc S., Wolf Susan M., Wolf Wendy A., Burke Wylie, Harley John, Myers Melanie, Namjou Bahram, Vinks Sander, Connolly John, Keating Brendan, Gerhard Glenn, Sundaresan Agnes, Tromp Gerard, Crosslin David, Leppig Kathy, Wicklund Cathy, Chute Christopher, Lynch John, De Andrade Mariza, Heit John, McCormick Jen, Brilliant Murray, Kitchner Terrie, Ritchie Marylyn, Böttinger Erwin, Peter Inga, Persell Stephen, Rasmussen-Torvik Laura, McGregor Tracy, Roden Dan, Antommaria Armand, Chiavacci Rosetta, Faucett Andy, Ledbetter David, Williams Janet, Hartzler Andrea, Vitek Carolyn R. Rohrer, Frost Norm, Ferryman Kadija, Horowitz Carol, Rhodes Rosamond, Zinberg Randi, Aufox Sharon, Pan Vivian, Long Rochelle, Ramos Erin, Odgis Jackie, Wise Anastasia, Hull Sara, Gitlin Jonathan, Green Robert, Metterville Danielle, McGuire Amy, Kong Sek Won, Trinidad Sue, Veenstra David, Roche Myra, Skinner Debra, Raspberry Kelly, O’Daniel Julianne, Parsons Will, Eng Christine, Hilsenbeck Susan, Karavite Dean, Conlin Laura, Spinner Nancy, Krantz Ian, Falk Marni, Santani Avni, Dechene Elizabeth, Dulik Matthew, Bernhardt Barbara, Schuetze Scott, Everett Jessica, Gornick Michele Caroline, Wilfond Ben, Tabor Holly, Lemke Amy A., Richards Sue, Goddard Katrina, Cooper Greg, East Kelly, Barsh Greg, Koenig Barbara, Van Allen Eliezer, Garber Judy, Garrett Jeremy, Zawati Ma’n, Lewis Michelle, Savage Sarah, Smith Maureen, Roychowdhury Sameek, Bailey Alice, Berkman Benjamin, Anan Charlisse Caga, Hindorff Lucia, Hutter Carolyn, King Rosalind, Li Rongling, Lockhart Nicole, McEwen Jean, Scholes Derek, Schully Sheri, Sun Kathie, Return of Genomic Results to Research Participants: The Floor, the Ceiling, and the Choices In Between, 10.1016/j.ajhg.2014.04.009
  11. Nuffield Council on Bioethics. Pharmacogenetics: ethical issues. London: Nuffield Foundation; 2003. http://nuffieldbioethics.org/wp-content/uploads/2014/07/Pharmacogenetics-Report.pdf . Accessed 19 Sept 2015.
  12. Fabsitz R. R., McGuire A., Sharp R. R., Puggal M., Beskow L. M., Biesecker L. G., Bookman E., Burke W., Burchard E. G., Church G., Clayton E. W., Eckfeldt J. H., Fernandez C. V., Fisher R., Fullerton S. M., Gabriel S., Gachupin F., James C., Jarvik G. P., Kittles R., Leib J. R., O'Donnell C., O'Rourke P. P., Rodriguez L. L., Schully S. D., Shuldiner A. R., Sze R. K. F., Thakuria J. V., Wolf S. M., Burke G. L., Ethical and Practical Guidelines for Reporting Genetic Research Results to Study Participants: Updated Guidelines From a National Heart, Lung, and Blood Institute Working Group, 10.1161/circgenetics.110.958827
  13. European Commission. 25 recommendations on the ethical, legal and social implications of genetic testing. Luxembourg: Office for Official Publications of European Communities; 2004. http://bookshop.europa.eu/en/25-recommendations-on-the-ethical-legal-and-social-implications-of-genetictesting-pbKINA21120/downloads/KI-NA-21-120-ENC/KINA21120ENC_002.pdf;pgid=y8dIS7GUWMdSR0EAlMEUUsWb0000PsOdKJz;sid=5VhRDgjRpFlRLFm9X_nPqWr04otX3Q8C44s=?FileName=KINA21120ENC_002.pdf&SKU=KINA21120ENC_PDF&CatalogueNumber=KI-NA-21-120-EN-C . Accessed 11 Oct 2016.
  14. du Bois Andreas, Floquet Anne, Kim Jae-Weon, Rau Joern, del Campo Josep M., Friedlander Michael, Pignata Sandro, Fujiwara Keiichi, Vergote Ignace, Colombo Nicoletta, Mirza Mansoor R., Monk Bradley J., Kimmig Rainer, Ray-Coquard Isabelle, Zang Rongyu, Diaz-Padilla Ivan, Baumann Klaus H., Mouret-Reynier Marie-Ange, Kim Jae-Hoon, Kurzeder Christian, Lesoin Anne, Vasey Paul, Marth Christian, Canzler Ulrich, Scambia Giovanni, Shimada Muneaki, Calvert Paula, Pujade-Lauraine Eric, Kim Byoung-Gie, Herzog Thomas J., Mitrica Ionel, Schade-Brittinger Carmen, Wang Qiong, Crescenzo Rocco, Harter Philipp, Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer, 10.1200/jco.2014.55.7348
  15. Bolton Kelly L., Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer, 10.1001/jama.2012.20
  16. Ledermann Jonathan, Harter Philipp, Gourley Charlie, Friedlander Michael, Vergote Ignace, Rustin Gordon, Scott Clare L, Meier Werner, Shapira-Frommer Ronnie, Safra Tamar, Matei Daniela, Fielding Anitra, Spencer Stuart, Dougherty Brian, Orr Maria, Hodgson Darren, Barrett J Carl, Matulonis Ursula, Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial, 10.1016/s1470-2045(14)70228-1
  17. Vencken P. M. L. H., Kriege M., Hoogwerf D., Beugelink S., van der Burg M. E. L., Hooning M. J., Berns E. M., Jager A., Collee M., Burger C. W., Seynaeve C., Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients, 10.1093/annonc/mdq628
  18. Alsop Kathryn, Fereday Sian, Meldrum Cliff, deFazio Anna, Emmanuel Catherine, George Joshy, Dobrovic Alexander, Birrer Michael J., Webb Penelope M., Stewart Colin, Friedlander Michael, Fox Stephen, Bowtell David, Mitchell Gillian, BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group, 10.1200/jco.2011.39.8545
  19. Harter Philipp, Johnson Toby, Berton-Rigaud Dominique, Park Sang-Yoon, Friedlander Michael, del Campo Josep M., Shimada Muneaki, Forget Frédéric, Mirza Mansoor R., Colombo Nicoletta, Zamagni Claudio, Chan John K., Imhof Martin, Herzog Thomas J., O'Donnell Dearbhaile, Heitz Florian, King Karen, Stinnett Sandy, Barrett Catherine, Jobanputra Minesh, Xu Chun-Fang, du Bois Andreas, BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study, 10.1016/j.ygyno.2015.12.027
  20. Johns Amber L, Miller David K, Simpson Skye H, Gill Anthony J, Kassahn Karin S, Humphris Jeremy L, Samra Jaswinder S, Tucker Katherine, Andrews Lesley, Chang David K, Waddell Nicola, Pajic Marina, Pearson John V, Grimmond Sean M, Biankin Andrew V, Zeps Nikolajs, , Returning individual research results for genome sequences of pancreatic cancer, 10.1186/gm558
  21. Richards Sue, Aziz Nazneen, Bale Sherri, Bick David, Das Soma, Gastier-Foster Julie, Grody Wayne W., Hegde Madhuri, Lyon Elaine, Spector Elaine, Voelkerding Karl, Rehm Heidi L., Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, 10.1038/gim.2015.30
  22. National Human Genome Research Institute. Breast cancer information core. 2015. http://research.nhgri.nih.gov/bic/ . Accessed 17 Dec 2013.
  23. Balmana J., Diez O., Rubio I. T., Cardoso F., , BRCA in breast cancer: ESMO Clinical Practice Guidelines, 10.1093/annonc/mdr373
  24. Engel Christoph, Fischer Christine, Breast Cancer Risks and Risk Prediction Models, 10.1159/000376600
  25. Gangi Alexandra, Cass Ilana, Paik Daniel, Barmparas Galinos, Karlan Beth, Dang Catherine, Li Andrew, Walsh Christine, Rimel Bobbie J., Amersi Farin F., Breast Cancer Following Ovarian Cancer inBRCAMutation Carriers, 10.1001/jamasurg.2014.1081
  26. Domchek Susan M., Jhaveri Komal, Patil Sujata, Stopfer Jill E., Hudis Clifford, Powers Jacquelyn, Stadler Zsofia, Goldstein Laura, Kauff Noah, Khasraw Mustafa, Offit Kenneth, Nathanson Katherine L., Robson Mark, Risk of metachronous breast cancer afterBRCAmutation-associated ovarian cancer, 10.1002/cncr.27842
  27. Gonzalez-Martín A., Bover I., Del Campo J. M., Redondo A., Vidal L., SEOM guideline in ovarian cancer 2014, 10.1007/s12094-014-1229-z
  28. Peterson J F, Field J R, Shi Y, Schildcrout J S, Denny J C, McGregor T L, Van Driest S L, Pulley J M, Lubin I M, Laposata M, Roden D M, Clayton E W, Attitudes of clinicians following large-scale pharmacogenomics implementation, 10.1038/tpj.2015.57
  29. Wolf Susan M., Crock Brittney N., Van Ness Brian, Lawrenz Frances, Kahn Jeffrey P., Beskow Laura M., Cho Mildred K., Christman Michael F., Green Robert C., Hall Ralph, Illes Judy, Keane Moira, Knoppers Bartha M., Koenig Barbara A., Kohane Isaac S., LeRoy Bonnie, Maschke Karen J., McGeveran William, Ossorio Pilar, Parker Lisa S., Petersen Gloria M., Richardson Henry S., Scott Joan A., Terry Sharon F., Wilfond Benjamin S., Wolf Wendy A., Managing incidental findings and research results in genomic research involving biobanks and archived data sets, 10.1038/gim.2012.23
  30. Bookman T. More People Seek Genetic Testing, But There Aren’t Enough Counselors. Shots-Health News From NPR. http://www.npr.org/sections/health-shots/2016/04/18/473066953/more-people-seek-genetic-testing-but-there-arent-enough-counselors . April 18, 2016. Accessed 23 May 2016.
  31. Cheon Jae Yeon, Mozersky Jessica, Cook-Deegan Robert, Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come?, 10.1186/s13073-014-0121-3
  32. Kolata G. When Gene Tests for Breast Cancer Reveal Grim Data but No Guidance. The New York Times. http://www.nytimes.com/2016/03/12/health/breast-cancer-brca-genetic-testing.html?_r=3 . March 11, 2016. Accessed 23 May 2016.
  33. Buchanan Adam Hudson, Rahm Alanna Kulchak, Williams Janter L., Alternate Service Delivery Models in Cancer Genetic Counseling: A Mini-Review, 10.3389/fonc.2016.00120
  34. Viberg Jennifer, Hansson Mats G, Langenskiöld Sophie, Segerdahl Pär, Incidental findings: the time is not yet ripe for a policy for biobanks, 10.1038/ejhg.2013.217
  35. Soini Sirpa, Genetic testing legislation in Western Europe—a fluctuating regulatory target, 10.1007/s12687-012-0078-0
  36. Barnes M, Stayn S, Forster D, Russell-Einhorn M, Peloquin D, Medina-Jordan A. The CLIA/HIPAA Conundrum of Returning Test Results to Research Participants. Bloomberg BNA: Medical Research Law & Policy Report. https://www.ropesgray.com/~/media/Files/articles/2015/July/2015-07-15-Bloomberg-BNA.ashx . Accessed 23 May 2016; 2015.
  37. U.S. Department of Health and Human Services. Attachment C: return of individual results and special considerations of issues arising from amendments of HIPAA and CLIA. 2015. http://www.hhs.gov/ohrp/sachrp-committee/recommendations/2015-september-28-attachment-c/index.html . Accessed 8 Aug 2016.
  38. Beskow Laura M., Burke Wylie, Fullerton Stephanie M., Sharp Richard R., Offering aggregate results to participants in genomic research: opportunities and challenges, 10.1038/gim.2011.62
  39. Branum R, Wolf SM. International policies on sharing genomic research results with relatives: approaches to balancing privacy with access. J Law Med Ethics. 2015;43(3):576–93. doi: 10.1111/jlme.12301 .
  40. European Commission. Regulation (EU) No 536/2014 of the European Parliament And Of The Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing directive 2001/20/EC text with EEA relevance. 2014. http://ec.europa.eu/health/files/eudralex/vol-1/reg_2014_536/reg_2014_536_en.pdf . Accessed 3 Aug 2015.
  41. Knoppers Bartha Maria, Deschênes Mylène, Zawati Ma’n H, Tassé Anne Marie, Population studies: return of research results and incidental findings Policy Statement, 10.1038/ejhg.2012.152